| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 30/01/2025 | 22:05 | Business Wire | GoodRx Announces Date for Fourth Quarter and Full Year 2024 Earnings Release and Conference Call | NASDAQ:GDRX | GoodRx Holdings Inc |
| 22/01/2025 | 23:02 | Edgar (US Regulatory) | Form 8-K - Current report | NASDAQ:GDRX | GoodRx Holdings Inc |
| 22/01/2025 | 23:00 | Business Wire | Scott Wagner Joins GoodRx Board of Directors | NASDAQ:GDRX | GoodRx Holdings Inc |
| 15/01/2025 | 23:56 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:GDRX | GoodRx Holdings Inc |
| 10/01/2025 | 17:00 | Business Wire | GoodRx Offering Free Telehealth Appointments to Los Angeles Residents Affected by Wildfires | NASDAQ:GDRX | GoodRx Holdings Inc |
| 09/01/2025 | 00:42 | Edgar (US Regulatory) | Form 3 - Initial statement of beneficial ownership of securities | NASDAQ:GDRX | GoodRx Holdings Inc |
| 18/12/2024 | 22:22 | Edgar (US Regulatory) | Form SCHEDULE 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend] | NASDAQ:GDRX | GoodRx Holdings Inc |
| 18/12/2024 | 22:05 | Business Wire | GoodRx to Participate in the 43rd Annual J.P. Morgan Healthcare Conference | NASDAQ:GDRX | GoodRx Holdings Inc |
| 17/12/2024 | 15:00 | Business Wire | GoodRx Report Shows Millions at Risk as Endocrinologist Shortages Hit Nearly 70% of U.S. Counties | NASDAQ:GDRX | GoodRx Holdings Inc |
| 16/12/2024 | 22:05 | Business Wire | GoodRx Appoints Healthcare Industry Veteran, Wendy Barnes, as New Chief Executive Officer | NASDAQ:GDRX | GoodRx Holdings Inc |
| 05/12/2024 | 15:00 | Business Wire | GoodRx Reveals Americans Overspent on Weight Loss Medications by $200 Million This Year, Fills Still Surged | NASDAQ:GDRX | GoodRx Holdings Inc |
| 13/11/2024 | 18:38 | PR Newswire (US) | Kuehn Law Encourages Investors of GoodRx Holdings, Inc. to Contact Law Firm | NASDAQ:GDRX | GoodRx Holdings Inc |
| 07/11/2024 | 20:01 | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:GDRX | GoodRx Holdings Inc |
| 07/11/2024 | 12:05 | Business Wire | GoodRx Reports Third Quarter 2024 Results | NASDAQ:GDRX | GoodRx Holdings Inc |
| 04/11/2024 | 22:05 | Business Wire | GoodRx to Participate in Upcoming Investor Conferences | NASDAQ:GDRX | GoodRx Holdings Inc |
| 31/10/2024 | 14:00 | Business Wire | GoodRx Unveils New E-commerce Platform, Launches with Opill® | NASDAQ:GDRX | GoodRx Holdings Inc |
| 29/10/2024 | 14:00 | Business Wire | GoodRx Announces Exclusive Low Cash Price for QSYMIA®, the Leading Branded Once-Daily Oral Weight Management Medication for Adults | NASDAQ:GDRX | GoodRx Holdings Inc |
| 28/10/2024 | 13:00 | Business Wire | Ronald E. Bruehlman Joins GoodRx Board of Directors | NASDAQ:GDRX | GoodRx Holdings Inc |
| 23/10/2024 | 15:00 | Business Wire | GoodRx Announces New Affordability Programs for Menopause Hormone Therapies | NASDAQ:GDRX | GoodRx Holdings Inc |
| 16/10/2024 | 15:00 | Business Wire | GoodRx Partnering with Retail Pharmacies to Deliver Pay-Over-Time Option Directly to Consumers | NASDAQ:GDRX | GoodRx Holdings Inc |
| 10/10/2024 | 23:41 | Business Wire | GoodRx Announces Date for Third Quarter 2024 Earnings Release and Conference Call | NASDAQ:GDRX | GoodRx Holdings Inc |
| 26/09/2024 | 15:00 | Business Wire | GoodRx Announces Lowest Discounted Cash Price at Retail Pharmacy Locations for neffy® (epinephrine nasal spray) | NASDAQ:GDRX | GoodRx Holdings Inc |
| 03/09/2024 | 22:43 | Edgar (US Regulatory) | Form 144 - Report of proposed sale of securities | NASDAQ:GDRX | GoodRx Holdings Inc |
| 08/08/2024 | 12:05 | Business Wire | GoodRx Reports Second Quarter 2024 Results | NASDAQ:GDRX | GoodRx Holdings Inc |
| 18/07/2024 | 12:00 | PR Newswire (US) | Boehringer Ingelheim and GoodRx announce exclusive patient affordability initiative for Adalimumab-adbm injection, Boehringer's biosimilar to Humira® | NASDAQ:GDRX | GoodRx Holdings Inc |
| 11/07/2024 | 15:00 | Business Wire | GoodRx Announces Date for Second Quarter 2024 Earnings Release and Conference Call | NASDAQ:GDRX | GoodRx Holdings Inc |
| 10/07/2024 | 15:00 | Business Wire | Ian T. Clark Joins GoodRx Board of Directors | NASDAQ:GDRX | GoodRx Holdings Inc |
| 26/06/2024 | 15:00 | Business Wire | GoodRx Launches New “Prescription Cost Tracker” to Spotlight Key Factors Driving Out-of-Pocket Medication Costs in the U.S. | NASDAQ:GDRX | GoodRx Holdings Inc |
| 20/06/2024 | 11:45 | PR Newswire (US) | GoodRx Holdings, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm Before June 21, 2024 to Discuss Your Rights - GDRX | NASDAQ:GDRX | GoodRx Holdings Inc |
| 17/06/2024 | 11:45 | PR Newswire (US) | The Gross Law Firm Reminds GoodRx Holdings, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of June 21, 2024 - GDRX | NASDAQ:GDRX | GoodRx Holdings Inc |
